Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy
Cengiz A, Wu CC, Lawley SD
Diabetes Obes Metab. Pub. online 14 Feb 2025.
Leggi
Islet transplantation versus standard of care for type 1 diabetes complicated by severe hypoglycemia from the collaborative islet transplant registry and the T1D exchange registry
Rickels MR, Ballou CM, Foster NC, et al.
Diabetes Care. 2025:dc241915.
Leggi
Diabetic gastroenteropathy: a pan-alimentary complication
Kornum DS, Krogh K, Keller J, et al.
Diabetologia. Pub. online 11 Feb 2025.
Leggi
Non-pharmacological management strategies for type 2 diabetes in children and young adults: a systematic review
Carino M, New RH, Nguyen J, et al.
Diabetes Res Clin Pract. 2025:112045.
Leggi
One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study
De Meulemeester J, Keymeulen B, De Block C, et al.
Diabetologia. Pub. online 11 Feb 2025.
Leggi
Mechanisms of diabetic cardiomyopathy: focus on inflammation
Bellemare M, Bourcier L, Iglesies-Grau J, et al.
Diabetes Obes Metab. Pub. online 10 Feb 2025.
Leggi
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Aggarwal R, Bhatt DL, Szarek M, et al.
Lancet Diabetes Endocrinol. Pub. online 13 Feb 2025.
Leggi
Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study
Ehrmann D, Krause-Steinrauf H, Uschner D, et al.
Diabetologia. Pub. online 14 Feb 2025.
Leggi
ANNALI AMD – “Analisi predittiva con Machine Learning – Pazienti con DMT2 trattati con analoghi del GLP1: probabilità di andare a target entro 1 anno dall’intensificazione con insulina”
Carissimi Soci, siamo lieti di condividere il report dell’analisi condotta con strumenti di machine learning, messo a punto dal Gruppo Intelligenza Artificiale e basato sui dati degli Annali AMD: “Analisi predittiva - Pazienti con diabete tipo 2 trattati con analoghi del GLP1: probabilità di andare a target entro 1 anno dall’intensificazione con insulina”.…
Leggi